BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 10459536)

  • 1. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
    Bruno B; Nash RA; Wallace PM; Gass MJ; Thompson J; Storb R; McSweeney PA
    Transplantation; 1999 Aug; 68(3):338-44. PubMed ID: 10459536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
    Barsoukov AA; Moore PF; Storb R; Santos EB; Sandmaier BM
    Transplantation; 1999 May; 67(10):1329-35. PubMed ID: 10360586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
    Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis.
    Bruno B; Goerner MA; Nash RA; Storb R; Kiem HP; McSweeney PA
    Biol Blood Marrow Transplant; 2001; 7(10):543-51. PubMed ID: 11760086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies that recognize canine CD34.
    McSweeney PA; Rouleau KA; Wallace PM; Bruno B; Andrews RG; Krizanac-Bengez L; Sandmaier BM; Storb R; Wayner E; Nash RA
    Blood; 1998 Mar; 91(6):1977-86. PubMed ID: 9490680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
    Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
    Clin Exp Immunol; 2001 Jan; 123(1):162-9. PubMed ID: 11168014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
    Transplantation; 2000 May; 69(10):2043-8. PubMed ID: 10852594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors.
    Yabe H; Yabe M; Hattori K; Hinohara T; Morimoto T; Nakamura Y; Noma M; Takei M; Kobayashi N; Tsuji K; Kato S
    Bone Marrow Transplant; 1996 Jun; 17(6):985-91. PubMed ID: 8807104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
    Zaucha JA; Yu C; Lothrop CD; Nash RA; Sale G; Georges G; Kiem HP; Niemeyer GP; Dufresne M; Cao Q; Storb R
    Biol Blood Marrow Transplant; 2001; 7(1):14-24. PubMed ID: 11215693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
    Burroughs L; Mielcarek M; Little MT; Bridger G; Macfarland R; Fricker S; Labrecque J; Sandmaier BM; Storb R
    Blood; 2005 Dec; 106(12):4002-8. PubMed ID: 16105977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of canine hematopoietic progenitor cells.
    Niemeyer GP; Hudson J; Bridgman R; Spano J; Nash RA; Lothrop CD
    Exp Hematol; 2001 Jun; 29(6):686-93. PubMed ID: 11378263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.